FIA
DMRA

FNY Investment Advisers’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

FNY Investment Advisers’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,680
Closed -$79K – 580
2022
Q3 		$79K Buy
+1,680
New +$85.2K 0.05% 178

Other funds holding DMRA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

FNY Investment Advisers's DMRA Position: Q4 2022 in Review

FNY Investment Advisers sold out of Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q4 2022, closing a stake of 1,680 shares — an estimated $79K sold.

FNY Investment Advisers first reported a position in DMRA in Q3 2022 and held it in 1 quarter. The position peaked at $79K in Q3 2022. 22 funds tracked by Wall St. Rank hold DMRA as of Q4 2022.

  • FNY Investment Advisers reported no remaining Damora Therapeutics, Inc. Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 1,680 Damora Therapeutics, Inc. Ordinary Shares shares in Q4 2022, an estimated $79K.
  • FNY Investment Advisers first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q3 2022 and held it in 1 quarter.
  • FNY Investment Advisers's Damora Therapeutics, Inc. Ordinary Shares position peaked at $79K in Q3 2022.
  • 22 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q4 2022.

Based on FNY Investment Advisers's 13F filing for Q4 2022, filed 10 Jan 2023.